Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOH_2025-12-20_015553Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of desogestrel and norethindrone in contraception, sponsored by ליאור שגב. Primary endpoints: Irregular bleeding and Mood effects. Planned start Nov 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on MOH_2025-12-20_015553.